Song, Eun Joo Professor

Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy

송은주 프로필 사진

				
  • Division Chair, Division of Pharmacy/Department Chair, Pharmacy
  • Science Building C #307
  • 02-3277-3373
  • Office hours
    • 월 17:00-18:00
Research Record
  • Practical magnetic bead-based capillary electrophoresis with laser-induced fluorescence for detecting endogenous miRNA in plasma Heliyon, 2023, v.9 no.12, e22809
    SCIE Scopus dColl.
  • Structural and functional characterization of USP47 reveals a hot spot for inhibitor design Communications Biology, 2023, v.6 no.1, 970
    SCIE Scopus dColl.
  • The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis Journal of Biomedical Science, 2023, v.30 no.1, 2
    SCIE Scopus dColl.
  • USP35 dimer prevents its degradation by E3 ligase CHIP through auto-deubiquitinating activity Cellular and Molecular Life Sciences, 2023, v.80 no.4, 112
    SCIE Scopus dColl.
  • Ubiquitin–proteasome system as a target for anticancer treatment—an update Archives of Pharmacal Research, 2023, v.46 no.7, 573-597
    SCIE Scopus KCI dColl.
  • Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR GENES, 2022, v.13 no.2, 328
    SCIE Scopus dColl.
  • MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11 CANCERS, 2022, v.14 no.4, 964
    SCIE Scopus dColl.
  • The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, v.14 no.6, mjac037
    SCIE Scopus dColl.
  • USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1 Cell Death Discovery, 2022, v.8 no.1, 24
    SCIE Scopus dColl.
  • Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease PROGRESS IN NEUROBIOLOGY, 2021, v.204, 102110
    SCIE Scopus dColl.
  • Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency BMC Biotechnology, 2021, v.21 no.1, 50
    SCIE Scopus dColl.
  • The Multifaceted Roles of USP15 in Signal Transduction International journal of molecular sciences, 2021, v.22 no.9, 0
    SCIE Scopus dColl.
  • UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation Nature Communications, 2021, v.12 no.1, 3291
    SCIE Scopus dColl.
  • A rapid and reliable CE-LIF method for the quantitative analysis of miRNA-497 in plasma and organs and its application to a pharmacokinetic and biodistribution study RSC ADVANCES, 2020, v.10 no.32, 18648-18654
    SCIE Scopus dColl.
  • Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity Biomedicine and Pharmacotherapy, 2020, v.121, 109613
    SCIE Scopus dColl.
  • Assay Systems for Profiling Deubiquitinating Activity International journal of molecular sciences, 2020, v.21 no.16, 0
    SCIE Scopus dColl.
  • Regulation of deubiquitinating enzymes by post-translational modifications International Journal of Molecular Sciences, 2020, v.21 no.11, 4028
    SCIE Scopus dColl.
  • Ribosomal protein S2 interplays with MDM2 to induce p53 Biochemical and Biophysical Research Communications, 2020, v.523 no.2, 0
    SCIE Scopus dColl.
  • USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2 CANCERS, 2020, v.12 no.5
    SCIE Scopus dColl.
  • Ubiquitin–proteasome system (UPS) as a target for anticancer treatment Archives of Pharmacal Research, 2020, v.43 no.11, 1144-1161
    SCIE Scopus KCI dColl.
  • Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability CELL DEATH & DISEASE, 2019, v.10, 570
    SCIE Scopus dColl.
  • Deubiquitinating Enzymes: A Critical Regulator of Mitosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.23, 5997
    SCIE Scopus dColl.
  • MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination MOLECULAR ONCOLOGY, 2019, v.13 no.12, 2663-2678
    SCIE Scopus dColl.
  • Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination JOURNAL OF MOLECULAR BIOLOGY, 2019, v.431 no.19, 3900-3912
    SCIE Scopus dColl.
  • [학술지논문] Practical magnetic bead-based capillary electrophoresis with laser-induced fluorescence for detecting endogenous miRNA in plasma HELIYON, 2023, v.9 no.12 , 22809-22809
    SCIE
  • [학술지논문] Structural and functional characterization of USP47 reveals a hot spot for inhibitor design COMMUNICATIONS BIOLOGY, 2023, v.6 no.1 , 970-970
    SCIE
  • [학술지논문] The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis JOURNAL OF BIOMEDICAL SCIENCE, 2023, v.30 no.1 , 2-2
    SCIE
  • [학술지논문] USP35 dimer prevents its degradation by E3 ligase CHIP through auto-deubiquitinating activity CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, v.80 no.4 , 112-112
    SCIE
  • [학술지논문] Ubiquitin-proteasome system as a target for anticancer treatment-an update ARCHIVES OF PHARMACAL RESEARCH, 2023, v.46 no.7 , 573-597
    SCIE
  • [학술지논문] Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR GENES, 2022, v.13 no.2 , 328-328
    SCIE
  • [학술지논문] MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11 CANCERS, 2022, v.14 no.4 , 964-964
    SCIE
  • [학술지논문] The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, v.14 no.6 , 037-037
    SCIE
  • [학술지논문] USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1 Cell Death Discovery, 2022, v.8 no.1 , 24-24
    SCIE
  • [학술지논문] Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease PROGRESS IN NEUROBIOLOGY, 2021, v.204 no.0 , 102110-102110
    SCI
  • [학술지논문] Evaluation of Pharmacokinetics and Metabolism of Phosphorothioate Antisense Oligonucleotide G3139 in Rat by Capillary Electrophoresis with Laser-Induced Fluorescence NUCLEIC ACID THERAPEUTICS, 2021, v.31 no.4 , 316-320
    SCI
  • [학술지논문] Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency BMC BIOTECHNOLOGY, 2021, v.21 no.1 , 50-50
    SCIE
  • [학술지논문] UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation NATURE COMMUNICATIONS, 2021, v.12 no.1 , 3291-3291
    SCI
  • [학술지논문] A rapid and reliable CE-LIF method for the quantitative analysis of miRNA-497 in plasma and organs and its application to a pharmacokinetic and biodistribution study RSC ADVANCES, 2020, v.10 no.32 , 18648-18654
    SCIE
  • [학술지논문] Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity BIOMEDICINE & PHARMACOTHERAPY, 2020, v.121 no.0 , 109613-109613
    SCI
  • [학술지논문] Assay Systems for Profiling Deubiquitinating Activity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.16 , 5638-5638
    SCIE
  • [학술지논문] Regulation of Deubiquitinating Enzymes by Post-Translational Modifications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.11 , 4028-4028
    SCIE
  • [학술지논문] Ribosomal protein S2 interplays with MDM2 to induce p53 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, v.523 no.2 , 542-547
    SCI
  • [학술지논문] USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2 CANCERS, 2020, v.12 no.5 , 542-547
    SCIE
  • [학술지논문] Ubiquitin-proteasome system (UPS) as a target for anticancer treatment ARCHIVES OF PHARMACAL RESEARCH, 2020, v.43 no.11 , 1144-1161
    SCIE
  • [학술지논문] Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability CELL DEATH & DISEASE, 2019, v.10 no.1 , 570-570
    SCIE
  • [학술지논문] Deubiquitinating Enzymes: A Critical Regulator of Mitosis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.23 , 5997-5997
    SCIE
  • [학술지논문] MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination Molecular Oncology, 2019, v.13 no.12 , 2663-2678
    SCIE
  • [학술지논문] Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination JOURNAL OF MOLECULAR BIOLOGY, 2019, v.431 no.19 , 3900-3912
    SCI
Courses
  • 2024-2nd

    • Pharmaceutical Instrumental Analysis

      • Subject No 37130Class No 01
      • 4Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A104) , Tue 4~4 (PHM-A400)
    • Pharmaceutical Analysis Ⅱ

      • Subject No 38938Class No 01
      • 2Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A404) , Thu 6~6 (POSCO462)
      • Major Requisite
    • Pharmaceutical Analysis Ⅱ

      • Subject No 38938Class No 02
      • 2Year ( 3Credit , 3Hour) Tue 6~6 (PHM-A404) , Thu 5~5 (POSCO462)
      • Major Requisite
    • Advanced Analysis in Biochemistry

      • Subject No G16887Class No 01
      • Year ( 3Credit , 3Hour) Fri 2~3 (PHM-A-204)
  • 2024-1st

    • Honors research

    • Pharmaceutical Analysis Ⅰ

      • Subject No 38930Class No 01
      • 2Year ( 3Credit , 3Hour) Mon 3~3 (POSCO552) , Fri 2~2 (POSCO451)
      • Major Requisite
    • Pharmaceutical Analysis Ⅰ

      • Subject No 38930Class No 02
      • 2Year ( 3Credit , 3Hour) Mon 2~2 (POSCO451) , Fri 3~3 (POSCO451)
      • Major Requisite
    • Introduction to Pharmaceutical Research

      • Subject No 38940Class No 01
      • 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
      • Major Requisite
    • Pharmaceutical Instrumental Analysis 강의 계획서 상세보기

      • Subject No 38950Class No 01
      • 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO555) , Thu 3~3 (POSCO)
    • Pharmaceutical Analysis Ⅰ

      • Subject No 39035Class No 01
      • 2Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A100-1) , Thu 2~2 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Instrumental Analysis 강의 계획서 상세보기

      • Subject No 39055Class No 01
      • 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO555) , Thu 3~3 (POSCO)
  • 2023-2nd

  • 2023-1st

  • 2022-2nd

    • Pharmaceutical Analysis II

      • Subject No 33963Class No 02
      • 3Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A100-1) , Wed 3~3 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Analysis II

      • Subject No 33963Class No 03
      • 3Year ( 3Credit , 3Hour) Mon 5~5 (POSCO552) , Wed 4~4 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 01
      • 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 02
      • 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 03
      • 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Instrumental Analysis

      • Subject No 37130Class No 01
      • 4Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Tue 2~2 (PHM-A104)
    • Advanced Pharmacy Practice and Research Ⅲ

      • Subject No 37156Class No 01
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Honors research

    • Lab rotation Ⅰ

      • Subject No 38927Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 38927Class No 02
      • 1Year ( 1.5Credit Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 39032Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
  • 2022-1st

    • Pharmaceutical Analysis I

      • Subject No 33502Class No 02
      • 3Year ( 3Credit , 3Hour) Wed 3~3 (PHM-A104) , Fri 3~3 (POSCO152)
      • Major Requisite
    • Pharmaceutical Analysis I

      • Subject No 33502Class No 03
      • 3Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A400) , Wed 4~4 (PHM-A104)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 01
      • 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 02
      • 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 03
      • 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A300)
      • Major Requisite
    • Seminar for Pharmaceutical Sciences III

      • Subject No G16849Class No 01
      • Year ( 3Credit , 3Hour) Thu 7~8 (-)
    • Seminar for Pharmaceutical Sciences Ⅲ

      • Subject No G18240Class No 01
      • Year ( 3Credit , 3Hour) Thu 7~8 (-)
  • 2021-2nd

    • Pharmaceutical Analysis II

      • Subject No 33963Class No 03
      • 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 3~3
      • Major Requisite
    • Pharmaceutical Analysis II

      • Subject No 33963Class No 04
      • 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 3~3
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 01
      • 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 02
      • 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 03
      • 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 04
      • 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Instrumental Analysis

      • Subject No 37130Class No 01
      • 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 3~3
    • Pharmaceutical Instrumental Analysis

      • Subject No 37130Class No 02
      • 4Year ( 3Credit , 3Hour) Tue 5~5 , Thu 4~4
    • Advanced Pharmacy Practice and Research Ⅲ

      • Subject No 37156Class No 01
      • 6Year ( 4Credit
      • Major Requisite
    • Honors research

      • Subject No 37803Class No 01
      • 4Year ( 1Credit , 1Hour)
  • 2021-1st

    • Pharmaceutical Analysis I

      • Subject No 33502Class No 02
      • 3Year ( 3Credit , 3Hour) Mon 2~2 , Wed 3~3
      • Major Requisite
    • Pharmaceutical Analysis I

      • Subject No 33502Class No 03
      • 3Year ( 3Credit , 3Hour) Mon 3~3 , Wed 2~2
      • Major Requisite
    • Pharmaceutical Analysis I

      • Subject No 33502Class No 04
      • 3Year ( 3Credit , 3Hour) Mon 2~2 , Wed 3~3
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 01
      • 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 02
      • 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A300)
      • Major Requisite
    • Pharmaceutical Experiment I

      • Subject No 37105Class No 03
      • 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A300)
      • Major Requisite
    • Honors research

      • Subject No 37803Class No 01
      • 4Year ( 1Credit , 1Hour)
Academic Background

Ewha Womans University 약학박사(분자생명과학부)

Ewha Womans University 약학석사(약학과)

Ewha Womans University 약학사(약학과)